Expression of Fluorescent Proteins in Branchiostoma lanceolatum by mRNA Injection into Unfertilized Oocytes
January 12th, 2015
We report here the robust and efficient expression of fluorescent proteins after mRNA injection into unfertilized oocytes of Branchiostoma lanceolatum. The development of the microinjection technique in this basal chordate will pave the way for far-reaching technical innovations in this emerging model system, including in vivo imaging and gene-specific manipulations.
Overview
This study demonstrates the effective expression of fluorescent proteins through mRNA injection into the unfertilized oocytes of Branchiostoma lanceolatum. The developed microinjection technique is expected to facilitate significant advancements in this model organism, particularly in in vivo imaging and gene manipulation.
Key Study Components
Area of Science
- Neuroscience
- Developmental Biology
- Fluorescent Imaging
Background
- Branchiostoma lanceolatum serves as an emerging model system in biological research.
- Fluorescent proteins are valuable tools for visualizing cellular processes.
- Microinjection techniques are critical for gene expression studies.
- In vivo imaging allows for real-time observation of developmental processes.
Purpose of Study
- To introduce mRNA encoding fluorescent proteins into oocytes.
- To enable in vivo imaging of developing embryos.
- To establish a reliable microinjection protocol for this model organism.
Methods Used
- Induction of spawning through a 24-hour temperature shock.
- Collection of oocytes and sperm in individual spawning cups.
- Microinjection of mRNA solution into the oocytes.
- Fertilization of oocytes with sperm drops.
Main Results
- Successful expression of fluorescent proteins in oocytes post-injection.
- Establishment of a microinjection technique suitable for Branchiostoma lanceolatum.
- Potential for future applications in gene-specific manipulations.
- Facilitation of in vivo imaging of embryonic development.
Conclusions
- The microinjection technique is robust and efficient.
- This method opens avenues for innovative research in developmental biology.
- Fluorescent imaging can enhance our understanding of embryonic processes.
Frequently Asked Questions
Executive Industry Relevance
Direct mRNA injection into unfertilized Branchiostoma lanceolatum oocytes enables precise, real-time visualization of embryonic cell behaviors, supporting early-stage target validation and mechanistic de-risking in developmental biology. This robust protocol enhances predictive confidence for gene function studies and facilitates translational continuity across model systems. The approach strengthens the utility of amphioxus as a foundational model for dissecting conserved developmental pathways relevant to biopharma R&D portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of gene function and pathway activity in a basal chordate system.
- Supports mechanistic de-risking by allowing live imaging of cellular dynamics post-manipulation.
- Facilitates functional target validation through gene-specific overexpression or knockdown.
- Improves predictive confidence for downstream translational studies.
Screening & Assay Development
- Provides a validated workflow for generating fluorescently labeled embryos suitable for quantitative imaging assays.
- Standardizes microinjection and imaging protocols for reproducibility across experiments.
- Enables scalable preparation of embryos for compound or genetic screening applications.
- Supports reliable evaluation of gene perturbation effects in a controlled system.
Translational & Preclinical Research
- Aligns with disease-relevant pathway analysis by leveraging conserved developmental mechanisms.
- Ensures continuity from discovery through preclinical validation using live imaging outputs.
- Reduces biological risk by providing early, quantitative readouts of gene function.
- Facilitates biomarker identification through dynamic visualization of developmental processes.
Pipeline & Workflow Integration
This microinjection and imaging protocol integrates at the interface of early discovery and preclinical research, enabling hypothesis-driven gene function studies and supporting lead identification decisions.
- Discovery Biology: Supports hypothesis testing and pathway clarification via live imaging of gene expression dynamics.
- Screening: Delivers reproducible, quantitative fluorescent readouts for comparative analysis.
- Analytics: Provides high-content imaging data to inform condition-specific effects and mechanistic insights.
- Translational Research: Bridges basic discovery with preclinical model validation through conserved developmental outputs.
- Enterprise Reuse: Establishes a reusable platform for gene manipulation and imaging in amphioxus and related systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in gene function studies.
- Operational Value: Standardizes microinjection and imaging workflows for reproducibility and scalability.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio advancement.
- Portfolio Impact: Supports risk-adjusted prioritization of targets and pathways for further development.
Implementation Considerations
- Requires technical expertise in microinjection and live imaging techniques.
- Demands access to specialized microscopy and injection instrumentation.
- Necessitates cross-team standardization of injection and imaging protocols.
- May require adaptation for use in other model systems or developmental stages.
- Dependent on oocyte and embryo quality for optimal reproducibility and data integrity.
Biopharma FAQs
Chapters in this video
0:05
Title
1:21
Poly-lysine Coated Dishes
2:04
Agarose Coated Dishes
2:38
Injection Mix and Loading Injection Needles
3:40
Sample Collection
4:38
Oocyte Injection
6:39
Fertilization, Selection, and Embryo Culture
7:55
Results: Expression of Fluorescent Proteins After mRNA Injection
8:56
Conclusion
